Long-Term Stock Portfolio: Best Stocks for 10 Years

7. Thermo Fisher Scientific Inc. (NYSE:TMO)

10-Year Revenue CAGR: 10.32%

Number of Hedge Fund Holders: 98

Thermo Fisher Scientific Inc. (NYSE:TMO) provides scientific instruments, laboratory equipment, reagents, and consumables among other products. It serves many customers, including pharmaceutical and biotechnology companies, hospitals and clinics, universities, and government research institutions. Its products and services are used in applications like drug discovery and development, clinical diagnostics, and life science research.

The company’s Q3 2024 success can be attributed to its “Trusted Partner” status, fostering strong commercial relationships that drive significant wins and solidify market leadership. This translated into a revenue of $10.6 billion for the third quarter, a 0.3% increase year-over-year. It prioritizes understanding customer needs through direct interactions and unparalleled access.

This understanding fueled strategic partnerships, such as the NCI myeloMATCH trial and collaborations in China. These partnerships demonstrate a commitment to advancing customer success and driving commercial wins. Thermo Fisher Scientific Inc.’s (NYSE:TMO) scale, expertise, and innovative solutions position it as the partner of choice for accelerating research and enhancing productivity.